On November 9, American biotech and pharmaceutical giant, Pfizer, and its German biotech partner, BioNTech, announced their researched coronavirus vaccine has proven to be more than 90% effective in preventing the virus among those without evidence of prior infection.
Indeed, Dr. Albert Bourla, chairman and CEO of Pfizer, hailed the recent trial results as “a great day for science and humanity.”